533 filings
Page 5 of 27
8-K
nn0cw
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
qp4og
24 Sep 20
JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
10:45am
8-K
rpay 9hfx9
21 Sep 20
Regulation FD Disclosure
9:15am
8-K
mokmm
16 Sep 20
JanOne Announces Strategic Plan to Divest its Legacy Businesses
4:29pm
8-K
zgxqiy89ir 63suxjtz
3 Sep 20
Other Events
1:30pm
8-K
j26mwg0zen 8imue
26 Aug 20
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
6:01am
8-K
uuxrnyi443
19 Aug 20
Regulation FD Disclosure
10:00am
8-K
ipo4c a1cn9jypuly3s
18 Aug 20
Regulation FD Disclosure
10:01am
8-K
94sa5ymcx esp2eb
12 Aug 20
Regulation FD Disclosure
6:03am
8-K
wbp eiajp2t8hkvs13
6 Aug 20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
2:45pm
8-K
781 y34woqh8y2ovd
30 Jul 20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
9:42am
8-K
hk7bxciaw0q1yzi fc
21 Jul 20
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
9:25am
8-K
nx2i7
8 Jul 20
Other Events
9:31am
8-K
g8dx 1ivqq
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
arnzpdbadu0iakwo
25 Jun 20
Other Events
10:00am
8-K
os9wwgz
18 Jun 20
JanOne Launches Strategic Alternatives Process for Legacy Businesses
9:38am